OneOme Institute


The OneOme Institute was established to facilitate the acceleration and adoption of pharmacogenomics (PGx) into patient care. As a part of OneOme, an industry leader in providing evidence-based PGx tests and provider tools, OneOme Institute focuses on bringing high-quality thought leadership and educational resources to healthcare providers across the globe.

OneOme Institute’s educational efforts are comprised of three key initiatives:


Coming soon! At these events, hosted by a carefully selected partner, attendees can gain first-hand experience with PGx testing and learn from OOI experts and industry peers how to effectively incorporate PGx into patient care.

Online courses

Coming soon! OneOme Institute’s proprietary courses are designed to give providers foundational knowledge about pharmacogenomics so they can successfully deploy programs within their practices.

OneOme Institute collaboration network

The collaboration network brings together PGx experts from around the world. These ambassadors collaborate on research and clinical trials and share their successes and best practices with peers worldwide.

Upcoming events

PGxperience symposia

Coming soon! We are working with several partners across the globe to schedule PGxperience (PGxP) events. Keep your eyes peeled for information about a PGxP symposium in your area.


PGxP event programs are developed in collaboration with a local host partner. In addition to plenary sessions / presentations on PGx and personalized medicine, the events provide networking opportunities and give attendees a chance to learn about PGx by interpreting their own RightMed test results. A member of the OneOme Institute will also present aggregated, de-identified PGx data.

Interested in hosting a PGxP event? CONTACT US to learn more about becoming a host partner!

Training courses

OneOme Institute will soon launch our Getting Started with PGx and RightMed course to give healthcare providers the foundational knowledge necessary to be successful with PGx. Check back soon to access the course.


Our library of curated third-party research and resources is designed to give you quick access to high-quality PGx information.


A comprehensive resource that curates knowledge about the impact of genetic variation on drug response for clinicians and researchers.

Pharmacogene Variation (PharmVar) Consortium

A central repository for pharmacogene (PGx) variation that focuses on haplotype structure and allelic variation.

Clinical Pharmacogenetics Implementation Consortium (CPIC®)

An international consortium of individual volunteers and a small dedicated staff who are interested in facilitating the use of pharmacogenetic tests for patient care.

FDA: Table of Pharmacogenomic Biomarkers in Drug Labeling

Lists therapeutic products with pharmacogenomic information found in the drug labeling.

Implementing Genomics in Practice (IGNITE)

A U.S.-based, NIH-funded network dedicated to supporting the implementation of genomics in healthcare.

Pharmacogenomics Research Network (PGRN)

Leads research in precision medicine for the discovery and translation of genomic variation influencing therapeutic and adverse drug effects.

U-PGx consortium (Europe)

Works to make effective treatment optimization accessible to every European citizen.

OneOme Institute members

OneOme Institute Ambassadors

Professor Dragan Primorac
Professor Dragan Primorac

Prof. Dragan Primorac is a pediatrician, forensic expert and geneticist. He is the first recipient of the title “Global Penn State University Ambassador”. Currently he serves as President of International Society for Applied Biological Sciences, Chair of the International Affairs Committee of the American Academy of Forensic Sciences, President of the State Competitiveness Cluster in Personalized Medicine, President of The Croatian Society for Human Genetics, Director of World Academy of Pain Medicine Ultrasonography (Central European Chapter), and as a member of the International Consortium for Personalized Medicine Executive Committee (IC PerMEd) established by The European Commission. Dr. Primorac is a professor at Eberly College of Science, Pennsylvania State University; Henry C. Lee College of Criminal Justice and Forensic Sciences, University of New Haven; Medical Schools in Split, Osijek, and Rijeka, Croatia; and the Department of Biotechnology, University of Rijeka, in Croatia. From 2003 to 2009 he served as Minister of Science, Education and Sports of The Republic of Croatia.

Dr. Paldeep Atwal
Dr. Paldeep Atwal

Dr. Atwal is a board-certified clinical and medical biochemical geneticist who formerly served at Mayo Clinic’s Jacksonville campus as medical director for the Center for Individualized Medicine and clinical lead for the Department of Clinical Genomics. He is a fellow of both The American College of Medical Genetics & Genomics and The Royal Colleges of Physicians of the United Kingdom. He received his medical degree from the University of Glasgow, Scotland and initially trained in hospital internal medicine with The Royal College of Physicians at Glasgow Royal Infirmary and various other hospitals around the Glasgow area. He completed his medical genetics residency at Stanford University Medical Center in Palo Alto, CA and his sub-specialty medical biochemical genetics fellowship at Baylor College of Medicine in Houston, TX. Additionally, he holds diplomas in Structural Molecular Biology and Forensic Medical Science.

Dr. Adrián Ortega Domínguez
Dr. Adrián Ortega Domínguez

Born in Guadalajara, Mexico on August 6, 1978, Dr. Ortega completed his medical degree at the University of Guadalajara in 2002 and his obstetrics and gynecology residence at the University of Guanajuato in 2007. That same year, he was accepted to get a degree in urogynecology at IMSS (Social Security Mexican Institute) at the CMNO (West Medical Center) in Guadalajara, Mexico, and in 2016, he received a degree in medical genetics at University of Valencia, Spain. He became involved in ALAMP (Latin American Precision Medicine Association) from 2012, as part of a group of health professionals who shared experiences and information about precision medicine through multiple conferences and seminars. In 2015 Dr. Ortega’s experience in precision medicine earned him an invitation to collaborate as medical director at Genomedik, the first precision medicine clinic in Mexico. Currently, Dr. Ortega works at IMSS as Division Chief of the OB/GYN department at the General Regional Hospital.

OneOme Institute team members

Morgan Donaldson
Morgan Donaldson - Director of International Business Development

Morgan Donaldson brings a background in biochemistry to her role at OneOme and has been a business development executive at several early to mid stage genomics startups in the San Francisco Bay area and in Canada. She is responsible for developing partnerships with some of the world’s leading hospitals and health systems to drive the implementation of pharmacogenomics in clinical care.

Bernard Esquivel, MD, PhD
Bernard Esquivel, MD, PhD - International Medical Director

Dr. Bernard Esquivel is leading the charge to bring pharmacogenomics into routine patient care across the world. A practicing immunologist, Dr. Esquivel has hands-on experience using pharmacogenomic testing for patients prior to prescribing, which he uses to help physicians around the world implement pharmacogenomics into patient care in their specialty areas. Dr. Esquivel received his MD from UNAM in Mexico and furthered his studies in medical genetics at Universidad de Valencia in Spain.

Erica Schnettler, PhD
Erica Schnettler, PhD - Medical Science Liaison

As a medical science liaison at OneOme, Erica specializes in educating and working with providers and health system partners to effectively implement PGx solutions in patient care. She received her Bachelors of Science in genetics from Iowa State University and her PhD in pharmacology from the University of Minnesota Medical School, where her research focused on cancer biomarkers.

Megan Adelman, PharmD
Megan Adelman, PharmD - Clinical Development Pharmacist

As a clinical development pharmacist at OneOme, Megan provides education and consults with providers and pharmacists. In addition, she supports clinical content through drug reviews and data curation. Megan received a bachelors of science and a Doctorate of Pharmacy degree with honors from the College of Pharmacy at North Dakota State University. She has specialized in pharmacogenomics since 2015.

Julie Ceno-England, MD
Julie Ceno-England, MD - Medical Advisor

Dr. Julie England is a Medical Advisor to OneOme, and is responsible for educating both providers and patients about PGx as well as leading the Medical Science Liaison team. She is a board-certified family medicine physician who completed her residency training at the University of Minnesota and has over 20 years experience in direct patient care. Dr. England is passionate about prevention and has advanced training in precision medicine and genomics.

Bronwyn Hartung, PhD, HCLD(ABB)
Bronwyn Hartung, PhD, HCLD(ABB) - Laboratory Director

Bronwyn leads laboratory operations at OneOme, including managing quality assurance and driving continuous improvement. She has 15 years of experience in molecular genetics, with expertise in the design and validation of laboratory-developed tests, clinical laboratory operations, quality systems, and regulatory compliance. Bronwyn earned her B.S. in Biology at Trinity University and her Ph.D. at Indiana University, followed by a postdoctoral fellowship in microbial pathology at the University of Iowa.